Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 23;23(6):1241.
doi: 10.3390/molecules23061241.

Design and Efficacy of Nanogels Formulations for Intranasal Administration

Affiliations
Review

Design and Efficacy of Nanogels Formulations for Intranasal Administration

Blessing A Aderibigbe et al. Molecules. .

Abstract

Nanogels are drug delivery systems that can bypass the blood-brain barrier and deliver drugs to the desired site when administered intranasally. They have been used as a drug delivery platform for the management of brain diseases such as Alzheimer disease, migraine, schizophrenia and depression. nanogels have also been developed as vaccine carriers for the protection of bacterial infections such as influenza, meningitis, pneumonia and as veterinary vaccine carriers for the protection of animals from encephalomyelitis and mouth to foot disease. It has been developed as vaccine carriers for the prevention of lifestyle disease such as obesity. Intranasal administration of therapeutics using nanogels for the management of brain diseases revealed that the drug transportation was via the olfactory nerve pathway resulting in rapid drug delivery to the brain with excellent neuroprotective effect. The application of nanogels as vaccine carriers also induced significant responses associated with protective immunity against selected bacterial and viral infections. This review provides a detailed information on the enhanced therapeutic effects, mechanisms and biological efficacy of nanogels for intranasal administration.

Keywords: Alzheimer disease; HIV; depression; hypertension; influenza; nanogels; obesity; veterinary vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Anatomy of the nose.
Figure 2
Figure 2
Pathways of nose-to-brain delivery.
Figure 3
Figure 3
Pathway of therapeutics to the brain.
Figure 4
Figure 4
Nanogel as vaccine carriers.

References

    1. Wyatt H.R. Update on treatment strategies for obesity. J. Clin. Endocrinol. Metab. 2013;98:1299–1306. doi: 10.1210/jc.2012-3115. - DOI - PMC - PubMed
    1. Jabeen H.D. Drug targets for obesity and depression: From serotonin to leptin. Curr. Drug Targets. 2016;17:1282–1291. doi: 10.2174/1389450117666151209123049. - DOI - PubMed
    1. Comerma-Steffensen S., Grann M.U., Andersen C., Rungby J., Simonsen U. Cardiovascular effects of current and future anti-obesity drugs. Curr. Vasc. Pharmacol. 2014;12:493–504. doi: 10.2174/1570161112666140423223529. - DOI - PubMed
    1. Feigin V.L., Abajobir A.A., Abate K.H., Abd-Allah F., Abdulle A.M., Abera S.F., Abyu G.Y., Ahmed M.B., Aichour A.N., Aichour I., et al. Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the global burden of disease Study 2015. Lancet Neurol. 2017;16:877–897. doi: 10.1016/S1474-4422(17)30299-5. - DOI - PMC - PubMed
    1. Neurological Diseases and Disorders Health Impacts of Climate Change Environmental Health Perspectives and the National Institute of Environmental Health Sciences 22 April 2010. [(accessed on 28 May 2017)]; Available online: https://www.niehs.nih.gov/health/materials/a_human_health_perspective_on....

LinkOut - more resources